The upcoming presentations will showcase research from different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel report. They will inform the community about the progress of Cancer Moonshot-funded projects, provide outreach related to Cancer Moonshot projects, enhance discussions and collaborations related to Cancer Moonshot research, and promote the sharing of data from Cancer Moonshot initiatives.
Need an Event Site?
The aim of the meeting is to promote trans-NIH research collaborations to address health disparities and inequities among Hispanic/Latino populations.
The last two and a half years have brought unprecedented changes to the world with the COVID-19 pandemic. In response to this challenge, the scientific community has mobilized on many fronts with advances in vaccines, diagnostics, treatments, pathology, immunology, virology, structural biology, cell biology, epidemiology and many other areas. However, many challenges still remain, particularly in the areas of long-term pathology, treatments, viral variants, and the development of broadly protective vaccines. To help facilitate interactions and highlight work from NIH/FDA investigators, the NIH/FDA COVID-19 scientific interest group is hosting our third workshop for NIH/FDA staff.
The goal of this Clinical Trials Planning Meeting is to develop clinical trials that optimize therapy under the ICI treatment paradigms.
The goal of the GI SPOREs Investigators meeting is the identification of new collaborative opportunities in prevention and treatment of GI and Pancreatic cancers and Neuroendocrine tumors within the SPORE research community.
This seminar series will highlight novel technologies that could transform cancer research and clinical care. These virtual monthly seminars will each showcase an innovative technology from an NCI-supported investigator, including the challenges and opportunities of technology development and how the tools can be used to advance cancer research. The seminar occurs at the end of every month on a Tuesday at 2:00pm ET and is held through Zoom.
To facilitate current NCI career development awardees and prospective applicants to become better acquainted with the elements involved in transitioning to research independence.
NCI-IOTN-SITC-AAI Workshop on Combining Immunotherapy with Radiotherapy: Opportunities and Challenges for Clinical Translation
The workshop will have short talks, panel discussions and interactive sessions that explore the integration of immunotherapies and radiation therapies for the treatment of cancer. Participants will include clinical researchers, translational and basic scientists, NCI staff and industry representatives.
Throughout the year, CCDI will host open Community Forums, which highlight CCDI progress and what’s on the horizon for the initiative. These forums cover CCDI programs, such as the Rare Pediatric Cancer Initiative and the CCDI Participant Index.
The National Cancer Institute (NCI) Office of Cancer Survivorship (OCS) is conducting a virtual event, Enhancing Capacity for Primary Care Research in Cancer Survivorship: A Workshop for Action, on February 28, 2024, to discuss research needs for addressing the intersection between primary care and cancer survivorship. The intended audience for this event is researchers, including clinician researchers, at every career stage who focus on any aspect of the intersection between primary care and survivorship. Registration is required in advance.
The NIH-CZI Junior Investigators Atlas Builders Meeting will be held March 17-19, 2024 at 6001 Executive Boulevard, Rockville, MD and virtually. This 2-day meeting will bring together biologists, physician scientists, computational biologists, and other computational experts in the early stages of their career from several on-going consortia.